Rafaella Abreu-Oberhuber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rafaella Abreu-Oberhuber has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carla Batissoco
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
2 shared publications - Danillo Alencar-Coutinho
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
2 shared publications - Jeanne Oiticica
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
2 shared publications - Karina Lezirovitz
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
2 shared publications - Maria Eduarda Paramo-Neto
Laboratório de Otorrinolaringologia Genética Molecular, Celular e Translacional/LIM32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo Brazil
2 shared publications - Ricardo Ferreira Bento
Department of Otorhinolaryngology, University of São Paulo School of Medicine, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (2) , 210-226
Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations
Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.
- 3 June 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (2) , 210-226
Open AccessGenetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations
Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.
- Open Access
- 24 April 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (02) , 001-011
A Structural Variant in the 5' Regulatory Region of DIAPH3 Segregates with Postlingual Hearing Loss and Auditory Neuropathy in a Multigenerational Brazilian Family
Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a DIAPH3 5'UTR deletion-insertion (c.-216_-46delinsAAGAA) that perfectly cosegregated with this specific phenotype. Notably, eight other affected relatives exhibited different clinical forms of hearing loss but did not carry the DIAPH3 variant, suggesting separate underlying causes for their symptoms. Identification of this regulatory structural variant supports the role of DIAPH3 in the etiological diagnosis of postlingual hearing loss and auditory neuropathy, with direct implications for genetic counseling and clinical management.
- 24 April 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (02) , 001-011
Open AccessA Structural Variant in the 5' Regulatory Region of DIAPH3 Segregates with Postlingual Hearing Loss and Auditory Neuropathy in a Multigenerational Brazilian Family
Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a DIAPH3 5'UTR deletion-insertion (c.-216_-46delinsAAGAA) that perfectly cosegregated with this specific phenotype. Notably, eight other affected relatives exhibited different clinical forms of hearing loss but did not carry the DIAPH3 variant, suggesting separate underlying causes for their symptoms. Identification of this regulatory structural variant supports the role of DIAPH3 in the etiological diagnosis of postlingual hearing loss and auditory neuropathy, with direct implications for genetic counseling and clinical management.